| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 4243-4249, Copyright © 1996 by Endocrine Society
ARTICLES |
B Le Magueresse-Battistoni, G Pernod, L Kolodie and M Benahmed
INSERM U-407, Centre Hospitalier Lyon-Sud, Grenoble, France.
In the present study we examined the in vitro regulation of plasminogen activator inhibitor I (PAI-1) expression in peritubular cells recovered from 20-day-old rat testes. We tested two growth factors, basic fibroblast growth factor (bFGF) and transforming growth factor-alpha (TGF alpha). They are synthesized by Sertoli cells, and peritubular cells exhibit the corresponding high affinity receptors. After exposure to bFGF or TGF alpha (0.1-30 ng/ml), PAI-1 messenger RNA levels, as determined by Northern hybridization analysis, increased in a dose- dependent manner. The first significant effects were noted after 2-h exposure to bFGF or TGF alpha (10 ng/ml), and PAI-1 messenger RNA levels were maximally stimulated approximately 12-fold (bFGF) and 8- fold (TGF alpha) after 4 h. The two growth factors increased the amount of immunoreactive (Western blots) and biologically active (Stachrom) PAI-1 measured in the culture medium. Actinomycin D inhibited the effects of these factors, whereas cycloheximide augmented them. Phorbol myristate acetate, an activator of protein kinase C, mimicked the effects of bFGF and TGF alpha. Interestingly, long term (24-h) pretreatment with phorbol myristate acetate resulted in a severe loss of responsiveness to bFGF or TGF alpha. Staurosporine, an inhibitor of protein kinase C, also significantly reduced the effects of bFGF and TGF alpha. Given that PAI-1 inhibits Sertoli cell plasminogen activator activity and that bFGF and TGF alpha are synthesized by Sertoli cells, these factors are likely to interact to regulate protease activity in localized regions of the seminiferous tubule.
This article has been cited by other articles:
![]() |
R E. Ramy, A Verot, S Mazaud, F Odet, S Magre, and B Le Magueresse-Battistoni Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis J. Endocrinol., October 1, 2005; 187(1): 135 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mruk and C. Y. Cheng Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis Endocr. Rev., October 1, 2004; 25(5): 747 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Le Magueresse-Battistoni, G. Pernod, F. Sigillo, L. Kolodié, and M. Benahmed Plasminogen Activator Inhibitor-1 Is Expressed in Cultured Rat Sertoli Cells Biol Reprod, July 1, 1998; 59(3): 591 - 598. [Abstract] [Full Text] |
||||
![]() |
L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Le Magueresse-Battistoni, G. Pernod, L. Kolodie, A.-M. Morera, and M. Benahmed Tumor Necrosis Factor-{alpha} Regulates Plasminogen Activator Inhibitor-1 in Rat Testicular Peritubular Cells Endocrinology, March 1, 1997; 138(3): 1097 - 1105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |